Healthy Adult Volunteers

3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bristol Myers Squibb
2 programs
2
BMS-986090Phase 11 trial
BMS-986196Phase 11 trial
Active Trials
NCT02079480Terminated130Est. Apr 2016
NCT06034899Withdrawn0Est. Nov 2023
Arrowhead Pharmaceuticals
1 program
1
VSA001 injectionPhase 11 trial
Active Trials
NCT05757596Completed24Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bristol Myers SquibbBMS-986196
Arrowhead PharmaceuticalsVSA001 injection
Bristol Myers SquibbBMS-986090

Clinical Trials (3)

Total enrollment: 154 patients across 3 trials

NCT06034899Bristol Myers SquibbBMS-986196

A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants

Start: Sep 2023Est. completion: Nov 20230
Phase 1Withdrawn
NCT05757596Arrowhead PharmaceuticalsVSA001 injection

Study of VSA001 Injection in Chinese Healthy Adult Volunteers

Start: May 2023Est. completion: Dec 202324 patients
Phase 1Completed
NCT02079480Bristol Myers SquibbBMS-986090

Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects

Start: May 2014Est. completion: Apr 2016130 patients
Phase 1Terminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space